Background. Randomized trials assessing BCG vaccine protection against tuberculosis have
widely varying results, for reasons that are not well understood. Methods. We examined …

Large numbers of people are being discharged from hospital following COVID-19 without
assessment of recovery. In 384 patients (mean age 59.9 years; 62% male) followed a median …

Two decades ago, WHO declared tuberculosis a global emergency, and invested in the highly
cost-effective directly observed treatment short-course programme to control the epidemic…

Background Prognostic models to predict the risk of clinical deterioration in acute COVID-19
cases are urgently required to inform clinical management decisions. Methods We …

Rationale New approaches to define factors underlying the immunopathogenesis of pulmonary
diseases including sarcoidosis and tuberculosis are needed to develop new treatments …

The number of proposed prognostic models for coronavirus disease 2019 (COVID-19) is
growing rapidly, but it is unknown whether any are suitable for widespread clinical …

The COVID-19 pandemic has currently overtaken every other health issue throughout the
world. There are numerous ways in which this will impact existing public health issues. Here …

Most individuals infected with Mycobacterium tuberculosis develop a latent infection, which
does not progress to active tuberculosis (TB). This occurs, in part, because infected …

Background. The benefit of highly active antiretroviral therapy (HAART) in the treatment of
patients coinfected with tuberculosis (TB) and human immunodeficiency virus (HIV) is unclear …

Background: Treatment of latent tuberculosis infection (LTBI) is an important component of
tuberculosis (TB) control, and this study updates a previous network meta-analysis of the best …